FFL
TEVA icon

Financial Freedom LLC’s Teva Pharmaceuticals TEVA Stock Holding History

Financial Freedom LLC’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$6.63K Hold
220
– – ﹤0.01% 346
2025
Q4 		$6.87K Hold
220
– – ﹤0.01% 286
2025
Q3 		$4.44K Hold
220
– – ﹤0.01% 315
2025
Q2 		$3.69K Hold
220
– – ﹤0.01% 317
2025
Q1 		$3.38K Hold
220
– – ﹤0.01% 327
2024
Q4 		$4.85K Hold
220
– – ﹤0.01% 315
2024
Q3 		$3.96K Hold
220
– – ﹤0.01% 317
2024
Q2 		$3.58K Hold
220
– – ﹤0.01% 327
2024
Q1 		$3.1K Hold
220
– – ﹤0.01% 324
2023
Q4 		$2.3K Hold
220
– – ﹤0.01% 328
2023
Q3 		$2.24K Hold
220
– – ﹤0.01% 338
2023
Q2 		$1.66K Hold
220
– – ﹤0.01% 363
2023
Q1 		$1.95K Hold
220
– – ﹤0.01% 357
2022
Q4 		$2.01K Buy
+220
New +$1.92K ﹤0.01% 354

Other funds holding TEVA

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
HIIFS
Harel Insurance Investments & Financial Services Ramat Gan, Israel $14.7B AUM 47% 1-Year Est. Return
PF
Phoenix Financial Givatayim, Israel $10.5B AUM 49.21% 1-Year Est. Return
MMH
Menora Mivtachim Holdings Ramat Gan, Israel $21.1B AUM 40.03% 1-Year Est. Return
WCM Investment Management
WCM Investment Management Laguna Beach, California $43.8B AUM 42.28% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $16.6B AUM 68.34% 1-Year Est. Return
MIFH
Migdal Insurance & Financial Holdings Petach Tikva, Israel $11.5B AUM 52.5% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
LIM
Lingotto Investment Management London, United Kingdom $5.06B AUM 91.14% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Financial Freedom LLC's TEVA Position: Q1 2026 in Review

Financial Freedom LLC held its Teva Pharmaceuticals (TEVA) position steady in Q1 2026 at 220 shares worth $6.63K. The position accounts for ﹤0.01% of the portfolio, ranked #346.

Financial Freedom LLC first reported a position in TEVA in Q4 2022 and has held it in 14 quarters since. The position peaked at $6.87K in Q4 2025. 651 funds tracked by Wall St. Rank hold TEVA as of Q1 2026.

  • Financial Freedom LLC held 220 shares of Teva Pharmaceuticals worth $6.63K as of Q1 2026.
  • Financial Freedom LLC left its Teva Pharmaceuticals share count unchanged in Q1 2026.
  • Teva Pharmaceuticals made up ﹤0.01% of Financial Freedom LLC's portfolio in Q1 2026, its #346 holding.
  • Financial Freedom LLC first reported a position in Teva Pharmaceuticals in Q4 2022 and has held it in 14 quarters since.
  • Financial Freedom LLC's Teva Pharmaceuticals position peaked at $6.87K in Q4 2025.
  • 651 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q1 2026.

Based on Financial Freedom LLC's 13F filing for Q1 2026, filed 30 Apr 2026.